无套内射无矿码免费看黄_亚洲精品嫩草AV在线观看_久久久久久国产精品免费免费男同_正在播放少妇呻吟对白_亚洲日韩欧美成人久久_色哟哟国产精品免费观看_4d肉蒲团之性奴大战奶水_人人妻人人澡人人爽_国产精品熟女在线视频_野外做受三级视频

美國(guó)Eutropics   
開(kāi)發(fā)了一種新的試驗(yàn)，以指導(dǎo)癌癥治療BH3分析生物標(biāo)志物采用專有技術(shù)，以取代目前的治療模式，提供更有針對(duì)性的治療。

Eutropics Pharmaceuticals develops a novel test to guide cancer treatment by employing proprietary BH3-profiling biomarker technology to replace current treatment paradigms with more targeted therapy. The biomarker provides a unique understanding of cancer cells that will be important in the clinical stages of development and in guiding the use of marketed cancer drugs. The BH3 profiling assay also provides a biomarker that is important in the pre-clinical development of experimental drugs, including the company’s first in class anti-cancer therapeutic lead compound.

Cancer cells survive due to blocks that prevent apoptosis: the drugs Eutropics Pharmaceuticals is developing trigger cell death in cancer cells that otherwise elude control.

A unique and powerful assay guides clinicians in the use of the drugs. The assay establishes where apoptosis is blocked and what specific protein is the cause. This tells clinicians in advance which patients will respond to ours and current therapeutics.

Disease targets include blood cancers, small cell lung cancers and ovarian cancer.